Cellebrite DI Ltd

CLBT

Equity

ISIN IL0011794802 / Valor 113481767

NASDAQ (2024-09-17)

USD 17.46-0.34%

Cellebrite DI Ltd
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Cellebrite DI Ltd, known by its Valor number 113481767, is a publicly traded company. The stock of the company is available through the stock provider NASDAQ. As of 17.09.2024, the current price of the stock is USD 17.46. The latest price change for this stock is -0.34%, which reflects the market’s response to various factors such as company performance, industry trends, and global economic conditions. The company has been evaluated by users of Umushroom, and has received a rating of 0 stars.

Summarized from source with an LLMView SourceSector: Technology

Revenue Growth

Cellebrite DI Ltd reported a revenue of $89.6 million for the first quarter of 2024, marking a 26% increase year-over-year. This growth was primarily driven by a 29% rise in subscription revenue, reflecting the company's successful expansion in its digital investigative solutions.

Annual Recurring Revenue

For the first quarter of 2024, Cellebrite DI Ltd achieved an Annual Recurring Revenue (ARR) of $331.8 million, which represents a 27% increase compared to the same period last year. This significant growth underscores the company's strong performance and customer retention.

Profitability

Cellebrite DI Ltd reported a GAAP net loss of $(71.4) million for the first quarter of 2024. However, on a non-GAAP basis, the company achieved a net income of $16.9 million, highlighting improved profitability and effective cost management strategies.

Adjusted EBITDA

In the first quarter of 2024, Cellebrite DI Ltd recorded an adjusted EBITDA of $17.6 million, with an adjusted EBITDA margin of 19.7%. This reflects the company's ability to maintain strong operational efficiency and profitability amidst its revenue growth.

Financial Outlook

Looking ahead, Cellebrite DI Ltd has reaffirmed its financial outlook for the full year of 2024. The company expects to achieve an ARR between $380 million and $400 million, and revenue in the range of $370 million to $380 million, indicating continued confidence in its growth trajectory and market demand for its solutions.

Summarized from source with an LLMView Source

Key figures

136%1Y

55.6%3Y

%5Y

Performance

36.2%1Y

51.0%3Y

46.1%5Y

Volatility